See More Hear More Watch More Hear More Get on iTunes
WSJ Daily Minute WSJMinute

Pfizer said to be in talks with Actavis

It’s believed that drug giant Pfizer explored a potential tax-lowering takeover of rival Actavis in recent weeks, but talks between the two pharmaceutical companies have now ended after Actavis decided against a deal.


More from